vs
Antero Midstream Corp（AM）与Tarsus Pharmaceuticals, Inc.（TARS）财务数据对比。点击上方公司名可切换其他公司
Antero Midstream Corp的季度营收约是Tarsus Pharmaceuticals, Inc.的1.9倍（$291.1M vs $151.7M），Antero Midstream Corp净利率更高（41.5% vs -5.5%，领先47.0%），Tarsus Pharmaceuticals, Inc.同比增速更快（128.4% vs -7.3%），Antero Midstream Corp自由现金流更多（$186.9M vs $13.0M），过去两年Tarsus Pharmaceuticals, Inc.的营收复合增速更高（134.4% vs 3.9%）
Antero Midstream Corp是美国能源企业，注册地为特拉华州，总部设于科罗拉多州丹佛市。公司全部油气储量均位于阿巴拉契亚盆地，采用水力压裂技术开采，核心业务涵盖油气勘探开发相关领域。
Tarsus Pharmaceuticals是一家处于后期临床阶段的生物制药公司，专注于眼科、皮肤科等专科领域创新疗法的研发和商业化，主打产品针对蠕形螨睑缘炎、玫瑰痤疮等未被充分诊断的常见病症，核心市场为美国。
AM vs TARS — 直观对比
营收规模更大
AM
是对方的1.9倍
$151.7M
营收增速更快
TARS
高出135.7%
-7.3%
净利率更高
AM
高出47.0%
-5.5%
自由现金流更多
AM
多$173.9M
$13.0M
两年增速更快
TARS
近两年复合增速
3.9%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $291.1M | $151.7M |
| 净利润 | $120.7M | $-8.4M |
| 毛利率 | — | — |
| 营业利润率 | 60.9% | -5.3% |
| 净利率 | 41.5% | -5.5% |
| 营收同比 | -7.3% | 128.4% |
| 净利润同比 | 2.1% | 63.8% |
| 每股收益（稀释后） | $0.25 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AMTARS
| Q1 26 | $291.1M | — | ||
| Q4 25 | $297.0M | $151.7M | ||
| Q3 25 | $294.8M | $118.7M | ||
| Q2 25 | $305.5M | $102.7M | ||
| Q1 25 | $291.1M | $78.3M | ||
| Q4 24 | $287.5M | $66.4M | ||
| Q3 24 | $269.9M | $48.1M | ||
| Q2 24 | $269.8M | $40.8M |
净利润AMTARS
| Q1 26 | $120.7M | — | ||
| Q4 25 | $51.9M | $-8.4M | ||
| Q3 25 | $116.0M | $-12.6M | ||
| Q2 25 | $124.5M | $-20.3M | ||
| Q1 25 | $120.7M | $-25.1M | ||
| Q4 24 | $111.2M | $-23.1M | ||
| Q3 24 | $99.7M | $-23.4M | ||
| Q2 24 | $86.0M | $-33.3M |
营业利润率AMTARS
| Q1 26 | 60.9% | — | ||
| Q4 25 | 33.8% | -5.3% | ||
| Q3 25 | 61.2% | -12.2% | ||
| Q2 25 | 61.0% | -21.6% | ||
| Q1 25 | 60.9% | -33.5% | ||
| Q4 24 | 61.8% | -36.8% | ||
| Q3 24 | 60.2% | -52.3% | ||
| Q2 24 | 56.6% | -81.6% |
净利率AMTARS
| Q1 26 | 41.5% | — | ||
| Q4 25 | 17.5% | -5.5% | ||
| Q3 25 | 39.3% | -10.6% | ||
| Q2 25 | 40.8% | -19.8% | ||
| Q1 25 | 41.5% | -32.1% | ||
| Q4 24 | 38.7% | -34.8% | ||
| Q3 24 | 37.0% | -48.7% | ||
| Q2 24 | 31.9% | -81.6% |
每股收益（稀释后）AMTARS
| Q1 26 | $0.25 | — | ||
| Q4 25 | $0.11 | $-0.17 | ||
| Q3 25 | $0.24 | $-0.30 | ||
| Q2 25 | $0.26 | $-0.48 | ||
| Q1 25 | $0.25 | $-0.64 | ||
| Q4 24 | $0.23 | $-0.57 | ||
| Q3 24 | $0.21 | $-0.61 | ||
| Q2 24 | $0.18 | $-0.88 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $180.4M | $417.3M |
| 总债务越低越好 | $3.2B | $72.4M |
| 股东权益账面价值 | $2.0B | $343.4M |
| 总资产 | $5.9B | $562.2M |
| 负债/权益比越低杠杆越低 | 1.63× | 0.21× |
8季度趋势，按日历期对齐
现金及短期投资AMTARS
| Q1 26 | $180.4M | — | ||
| Q4 25 | $180.4M | $417.3M | ||
| Q3 25 | — | $401.8M | ||
| Q2 25 | — | $381.1M | ||
| Q1 25 | — | $407.9M | ||
| Q4 24 | — | $291.4M | ||
| Q3 24 | — | $317.0M | ||
| Q2 24 | — | $323.6M |
总债务AMTARS
| Q1 26 | $3.2B | — | ||
| Q4 25 | $3.2B | $72.4M | ||
| Q3 25 | $3.0B | $72.3M | ||
| Q2 25 | $3.0B | $72.1M | ||
| Q1 25 | $3.1B | $72.0M | ||
| Q4 24 | $3.1B | $71.8M | ||
| Q3 24 | $3.2B | $71.7M | ||
| Q2 24 | $3.2B | $71.6M |
股东权益AMTARS
| Q1 26 | $2.0B | — | ||
| Q4 25 | $2.0B | $343.4M | ||
| Q3 25 | $2.1B | $335.1M | ||
| Q2 25 | $2.1B | $332.6M | ||
| Q1 25 | $2.1B | $342.5M | ||
| Q4 24 | $2.1B | $224.5M | ||
| Q3 24 | $2.1B | $237.5M | ||
| Q2 24 | $2.1B | $252.2M |
总资产AMTARS
| Q1 26 | $5.9B | — | ||
| Q4 25 | $5.9B | $562.2M | ||
| Q3 25 | $5.7B | $534.6M | ||
| Q2 25 | $5.7B | $495.0M | ||
| Q1 25 | $5.8B | $500.8M | ||
| Q4 24 | $5.8B | $377.0M | ||
| Q3 24 | $5.8B | $376.3M | ||
| Q2 24 | $5.8B | $376.8M |
负债/权益比AMTARS
| Q1 26 | 1.63× | — | ||
| Q4 25 | 1.63× | 0.21× | ||
| Q3 25 | 1.46× | 0.22× | ||
| Q2 25 | 1.45× | 0.22× | ||
| Q1 25 | 1.49× | 0.21× | ||
| Q4 24 | 1.47× | 0.32× | ||
| Q3 24 | 1.49× | 0.30× | ||
| Q2 24 | 1.50× | 0.28× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $198.9M | $19.3M |
| 自由现金流经营现金流 - 资本支出 | $186.9M | $13.0M |
| 自由现金流率自由现金流/营收 | 64.2% | 8.6% |
| 资本支出强度资本支出/营收 | 11.1% | 4.2% |
| 现金转化率经营现金流/净利润 | 1.65× | — |
| 过去12个月自由现金流最近4个季度 | — | $-22.3M |
8季度趋势，按日历期对齐
经营现金流AMTARS
| Q1 26 | $198.9M | — | ||
| Q4 25 | $255.5M | $19.3M | ||
| Q3 25 | $212.8M | $18.3M | ||
| Q2 25 | $265.2M | $-29.4M | ||
| Q1 25 | $198.9M | $-20.7M | ||
| Q4 24 | $232.7M | $-22.2M | ||
| Q3 24 | $184.9M | $-8.7M | ||
| Q2 24 | $215.8M | $-14.4M |
自由现金流AMTARS
| Q1 26 | $186.9M | — | ||
| Q4 25 | — | $13.0M | ||
| Q3 25 | — | $16.3M | ||
| Q2 25 | — | $-30.4M | ||
| Q1 25 | — | $-21.2M | ||
| Q4 24 | — | $-22.3M | ||
| Q3 24 | $184.3M | $-8.9M | ||
| Q2 24 | $147.2M | $-15.4M |
自由现金流率AMTARS
| Q1 26 | 64.2% | — | ||
| Q4 25 | — | 8.6% | ||
| Q3 25 | — | 13.8% | ||
| Q2 25 | — | -29.6% | ||
| Q1 25 | — | -27.1% | ||
| Q4 24 | — | -33.5% | ||
| Q3 24 | 68.3% | -18.6% | ||
| Q2 24 | 54.6% | -37.8% |
资本支出强度AMTARS
| Q1 26 | 11.1% | — | ||
| Q4 25 | — | 4.2% | ||
| Q3 25 | — | 1.6% | ||
| Q2 25 | — | 1.0% | ||
| Q1 25 | — | 0.8% | ||
| Q4 24 | 0.0% | 0.1% | ||
| Q3 24 | 0.2% | 0.6% | ||
| Q2 24 | 25.4% | 2.5% |
现金转化率AMTARS
| Q1 26 | 1.65× | — | ||
| Q4 25 | 4.92× | — | ||
| Q3 25 | 1.84× | — | ||
| Q2 25 | 2.13× | — | ||
| Q1 25 | 1.65× | — | ||
| Q4 24 | 2.09× | — | ||
| Q3 24 | 1.85× | — | ||
| Q2 24 | 2.51× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AM
| Gathering and compression–Antero Resources | $238.0M | 82% |
| Other | $52.3M | 18% |
| Water handling–third party | $505.0K | 0% |
| Gathering and compression–third party | $295.0K | 0% |
TARS
暂无分部数据
